Rhinoplasty, edema, pain and swelling after septorhinoplasty surgery. Encounter for cosmetic surgery
Conditions
Interventions
Intervention 1: Intervention group: Patients aged 18-45 years who are candidates for primary septorhinoplasty are being evaluated for the effectiveness of the drug bromelain, brand name Brozyme Ultra,
Sponsors
Rasht University of Medical Sciences
Techra Pharmed
Eligibility
Sex/Gender
All
Age
18 Years to 45 Years
Inclusion criteria
Inclusion criteria: Patients in the age group of 18-45 years candidates for primary open septorhinoplasty surgery
Exclusion criteria
Exclusion criteria: pregnancy Kidney , liver disease Hypertension Bleeding disorders Corticosteroid use for more than a week Roaccutane use Patients who experienced any complications from this drug
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Edema based on the thickness of the nasal skin. Timepoint: Assessments are performed before the intervention and before surgery (baseline), and then 4 weeks after the intervention. Method of measurement: Edema measurement criteria based on ultrasound ( GE Voluson E6 ).;Ecchymosis. Timepoint: Ecchymosis assessment will be performed at weeks 1, 2, and 3 after the intervention. Method of measurement: Ecchymosis is assessed using the Ecchymosis Grading Scale, a clinical scoring scale that grades the severity of bruising around the eyes based on the extent and intensity of the discoloration.;Pain. Timepoint: Pain is assessed in the first 24 hours after surgery and then at weeks 1 and 2 after the intervention. Method of measurement: Assessment with the Visual Analogue Scale from 0-10 based on patient report. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMaliheh Akbarpour
Rasht University of Medical Sciences
Outcome results
None listed